Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: early and midterm outcomes

EuroIntervention 2017;13:e1032-e1039 published online ahead of print September 2017 published online e-edition October 2017. DOI: 10.4244/EIJ-D-17-00193

Marianna Adamo
Marianna Adamo1*, MD; Claudia Fiorina1, MD; Salvatore Curello1, MD; Giuliano Chizzola1, MD; Elena Pezzotti1,2, MD; Emanuele Gavazzi3, MD; Luca Branca1,2, MD; Ermanna Chiari2, MD; Filippo Quinzani1,2, MD; Michele Rinaldi4, M.Eng; Marco Metra2, MD; Federica Ettori1, MD
1. Cardiac Catheterisation Laboratory, Cardiothoracic Department, Spedali Civili, Brescia, Italy; 2. Division of Cardiology, Cardiothoracic Department, Spedali Civili, University of Brescia, Brescia, Italy; 3. Department of Radiology, Spedali Civili, Univ

Aims: The aim of this study was to report clinical outcomes of self-expanding transcatheter aortic valve implantation (TAVI) for failed small Mitroflow (MF) bioprostheses.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary occlusiontranscatheter aortic valve implantationvalve-in-valve
Read next article
Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre “CE-approval cohort”

Latest news